Celgene is now part of Bristol-Myers Squibb
Select continue for information about Celgene.
Select BMS to learn about Bristol-Myers Squibb.
Be a game-changer in CAR T
We’re leading the way in Chimeric Antigen Receptor T-Cell therapy (CAR T). You can too. This emerging immunotherapy reprograms a patient’s own CD4+ and CD8+ T cells to recognize and attack cancer. Now, we’re exploring even more possibilities through a number of clinical trials. And as we continue to expand, we’re looking for quality-focused, passionate people to help us dive deeper and go further. Bring your love of innovation and desire to make an impact to this exciting field today.
From Manufacturing Managers to Principal Scientists, explore how you can find your unique spot on our CAR T team today.
Our unique culture
Bring your inventive gene
Andreia talks about making an impact
Jaymes talks about our commitment to patients
Join our future-focused team
If you’re looking for an environment where you can bring your unique skills to make a difference, find out how you can be an innovator in the world of CAR T. Here, your drive to do groundbreaking and meaningful work will help you thrive.Learn how you can be a part of the team that is taking cell therapy to the next level. Explore roles now.